These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14998633)

  • 21. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.
    Camenzind E; Steg PG; Wijns W
    Circulation; 2007 Mar; 115(11):1440-55; discussion 1455. PubMed ID: 17344324
    [No Abstract]   [Full Text] [Related]  

  • 23. The FDA and the physician.
    Fredd S
    Am J Gastroenterol; 1988 Oct; 83(10):1088-90. PubMed ID: 3421218
    [No Abstract]   [Full Text] [Related]  

  • 24. The turmoil around the drug-eluting stents.
    Werkö L
    Scand Cardiovasc J; 2007 Jun; 41(3):131-2. PubMed ID: 17487758
    [No Abstract]   [Full Text] [Related]  

  • 25. Combatting medical quackery: a message to the physicians of Rhode Island.
    Scott HD
    R I Med J (1976); 1990 Apr; 73(4):141-3. PubMed ID: 2336518
    [No Abstract]   [Full Text] [Related]  

  • 26. TCT 2005 late-breaking trials promise to influence practice patterns.
    White J
    J Interv Cardiol; 2006 Feb; 19(1):113-6. PubMed ID: 16483351
    [No Abstract]   [Full Text] [Related]  

  • 27. The practitioner's role in detection of adverse drug reactions.
    Soffer A
    Arch Intern Med; 1985 Feb; 145(2):232-3. PubMed ID: 3838430
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medicine, physicians and the media].
    Küss R
    Bull Acad Natl Med; 1987 Jun; 171(6):733-4. PubMed ID: 3325147
    [No Abstract]   [Full Text] [Related]  

  • 29. Fractured DES with a patent coronary artery: clinical implications.
    Park JS; Shin DG; Kim YJ
    J Invasive Cardiol; 2007 Feb; 19(2):E43-5. PubMed ID: 17268051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCT Daily: ABSORB: bioabsorbable coronary stents successfully and safely deployed.
    J Interv Cardiol; 2007 Feb; 20(1):36-7. PubMed ID: 17300400
    [No Abstract]   [Full Text] [Related]  

  • 31. Coronary stents. Keeping vessels open.
    Mayo Clin Health Lett; 2007 Jun; 25(6):1-3. PubMed ID: 17577936
    [No Abstract]   [Full Text] [Related]  

  • 32. All drug-eluting stents are equal, but some drug-eluting stents are more equal than others.
    Strauss BH
    J Am Coll Cardiol; 2006 Oct; 48(7):1310-1. PubMed ID: 17010787
    [No Abstract]   [Full Text] [Related]  

  • 33. American Orthopaedic Association symposium: Evaluating the flood of orthopaedic media and marketing information.
    Purvis JM; Alexander AH; Einhorn TA; Griffin LY
    J Bone Joint Surg Am; 2005 Jun; 87(6):1392-8. PubMed ID: 15930553
    [No Abstract]   [Full Text] [Related]  

  • 34. Is this the best way to bring medicine to the masses? Doctors of the airwaves.
    Gold M
    New Physician; 1988 Nov; 37(8):21-4. PubMed ID: 10292876
    [No Abstract]   [Full Text] [Related]  

  • 35. President's page: the FACCs of quality.
    Bove AA; Cacchione JG; Kovacs RJ
    J Am Coll Cardiol; 2010 Mar; 55(9):922-5. PubMed ID: 20185046
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 37. Acne drug controversy ignites turf battle over prescribing.
    Thomas P
    Med World News; 1988 Jun; 29(11):46-7. PubMed ID: 10313737
    [No Abstract]   [Full Text] [Related]  

  • 38. 'Dear doctor...'--evaluating the impact of risk communication efforts.
    Seligman PJ
    Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):291-3. PubMed ID: 12812008
    [No Abstract]   [Full Text] [Related]  

  • 39. Percutaneous treatment of coronary bifurcation lesions in the era of drug-eluting stents.
    Costa RA; Moussa ID
    Minerva Cardioangiol; 2006 Oct; 54(5):577-89. PubMed ID: 17019395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving use of drug-eluting stents in diabetic patients.
    Skelding KA; Young JJ
    J Invasive Cardiol; 2005 Jul; 17(7):349-51. PubMed ID: 16003017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.